ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Chengfeng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2126-6572; OpenAlex author ID A5101515226. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. Last author DOI 10.3389/fmolb.2022.1036287 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaohao Zheng · 1 shared paper, 2022 · strength 0.20
- Paper Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G an… DOI 10.3389/fmolb.2022.1036287 ↗
Zongting Gu · 1 shared paper, 2022 · strength 0.20
- Paper Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G an… DOI 10.3389/fmolb.2022.1036287 ↗
Yongxing Du · 1 shared paper, 2022 · strength 0.20
- Paper Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G an… DOI 10.3389/fmolb.2022.1036287 ↗
Yunjie Duan · 1 shared paper, 2022 · strength 0.20
- Paper Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G an… DOI 10.3389/fmolb.2022.1036287 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.